Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 7760610)

1.

Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.

Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ, O'Meara A, Cornu G, Souillet G, Frappaz D, et al.

Lancet. 1995 Jun 3;345(8962):1398-402.

PMID:
7760610
2.

[Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].

Maaswinkel-Mooij PD, Poorthuis BJ, Hoogerbrugge PM, Brouwer OF, Vossen JM.

Ned Tijdschr Geneeskd. 1998 Jan 24;142(4):169-74. Review. Dutch.

PMID:
9557021
3.

Therapeutic approaches to lysosomal storage diseases.

Kaye EM.

Curr Opin Pediatr. 1995 Dec;7(6):650-4. Review.

PMID:
8776014
4.

New prospects for the treatment of lysosomal storage diseases.

Schiffmann R, Brady RO.

Drugs. 2002;62(5):733-42. Review.

PMID:
11929328
5.

Bone marrow transplantation and gene therapy for lysosomal storage diseases.

Hoogerbrugge PM, Valerio D.

Bone Marrow Transplant. 1998 Apr;21 Suppl 2:S34-6. Review.

PMID:
9630322
6.

[Treatment prospects of lysosomal storage disorders].

Reismann P, Tulassay Z.

Orv Hetil. 2008 Jun 22;149(25):1171-9. doi: 10.1556/OH.2008.28382. Review. Hungarian.

PMID:
18547894
7.

[Gaucher disease: diagnosis and treatment].

Fumić K, Stavljenić-Rukavina A, Mrsić M, Potocki K.

Acta Med Croatica. 2004;58(5):353-8. Review. Croatian.

PMID:
15756799
8.
9.

[Gaucher's disease: pathogenesis, diagnosis and therapy].

Pregun I, Tulassay Z.

Orv Hetil. 2004 Sep 12;145(37):1883-90. Review. Hungarian.

PMID:
15493618
10.

[Bone marrow transplantation for lysosomal storage diseases].

Imaizumi M.

Nihon Rinsho. 1995 Dec;53(12):3083-8. Review. Japanese.

PMID:
8577063
11.

New concepts in the diagnosis and treatment of lysosomal and peroxisomal disorders.

Moser HW.

Curr Opin Neurol Neurosurg. 1992 Jun;5(3):355-8. Review.

PMID:
1623264
12.

Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.

van Leeuwen JE, van Tol MJ, Joosten AM, Schellekens PT, van den Bergh RL, Waaijer JL, Oudeman-Gruber NJ, van der Weijden-Ragas CP, Roos MT, Gerritsen EJ, et al.

Blood. 1994 Dec 1;84(11):3936-47. Review.

13.

Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.

Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, Lisowska-Grospierre B, Griscelli C, Fischer A.

Blood. 1995 Jan 15;85(2):580-7. Review.

14.

The status of hematopoietic stem cell transplantation in lysosomal storage disease.

Malatack JJ, Consolini DM, Bayever E.

Pediatr Neurol. 2003 Nov;29(5):391-403. Review.

PMID:
14684234
15.

The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders.

Clarke LA, Hollak CE.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):219-35. doi: 10.1016/j.beem.2014.08.010. Epub 2014 Aug 27. Review.

PMID:
25987175
16.

Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments.

Pastores GM, Hughes DA.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):173-82. doi: 10.1016/j.beem.2014.08.005. Epub 2014 Aug 27. Review.

PMID:
25987171
17.

The role of antibodies in enzyme treatments and therapeutic strategies.

Bigger BW, Saif M, Linthorst GE.

Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):183-94. doi: 10.1016/j.beem.2015.01.006. Epub 2015 Jan 24. Review.

PMID:
25987172
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk